Colon polyps screening: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
*There is insufficient evidence to recommend routine screening for colon polyps in general population. | *There is insufficient evidence to recommend routine screening for colon polyps in general population. | ||
*According to guidelines for colonoscopy surveillance after screening and polypectomy by the US Multi-Society Task Force on Colorectal Cancer recommendations for surveillance and screening are as follows:<ref name="pmid22763141">{{cite journal |vauthors=Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR |title=Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer |journal=Gastroenterology |volume=143 |issue=3 |pages=844–857 |year=2012 |pmid=22763141 |doi=10.1053/j.gastro.2012.06.001 |url=}}</ref><ref>National Guideline Clearinghouse (NGC). Guideline summary: Follow-up of colorectal polyps or cancer. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 Jan 16. [cited 2017 Dec 28]. Available: https://www.guideline.gov</ref><ref name="pmid28555630">{{cite journal |vauthors=Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ |title=Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer |journal=Am. J. Gastroenterol. |volume=112 |issue=7 |pages=1016–1030 |year=2017 |pmid=28555630 |doi=10.1038/ajg.2017.174 |url=}}</ref> | *According to guidelines for colonoscopy surveillance after screening and polypectomy by the US Multi-Society Task Force on Colorectal Cancer, recommendations for surveillance and screening are as follows:<ref name="pmid22763141">{{cite journal |vauthors=Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR |title=Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer |journal=Gastroenterology |volume=143 |issue=3 |pages=844–857 |year=2012 |pmid=22763141 |doi=10.1053/j.gastro.2012.06.001 |url=}}</ref><ref>National Guideline Clearinghouse (NGC). Guideline summary: Follow-up of colorectal polyps or cancer. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 Jan 16. [cited 2017 Dec 28]. Available: https://www.guideline.gov</ref><ref name="pmid28555630">{{cite journal |vauthors=Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ |title=Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer |journal=Am. J. Gastroenterol. |volume=112 |issue=7 |pages=1016–1030 |year=2017 |pmid=28555630 |doi=10.1038/ajg.2017.174 |url=}}</ref> | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="3" |Baseline colonoscopy | ! colspan="3" |Baseline colonoscopy | ||
Revision as of 02:21, 28 December 2017
|
Colon polyps Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Colon polyps screening On the Web |
|
American Roentgen Ray Society Images of Colon polyps screening |
|
Risk calculators and risk factors for Colon polyps screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for colon polyps.
Screening
- There is insufficient evidence to recommend routine screening for colon polyps in general population.
- According to guidelines for colonoscopy surveillance after screening and polypectomy by the US Multi-Society Task Force on Colorectal Cancer, recommendations for surveillance and screening are as follows:[1][2][3]
| Baseline colonoscopy | Recommendation | ||
|---|---|---|---|
| No polyps | Colonoscopy every 10 years | ||
| Polyps | Hyperplastic polyps | Size <10 mm | Colonoscopy every 10 years |
| Adenomatous polyps | 1-2 tubular adenomas <10 mm | Colonoscopy every 5-10 years | |
| 3-10 tubular adenomas <10 mm | Colonoscopy every 3 years | ||
| >10 adenomas | Colonoscopy <3 years | ||
| Tubular adenomas ≥10 mm | Colonoscopy every 3 years | ||
| Villous adenomas | Colonoscopy every 3 years | ||
| Adenoma with high grade dysplasia | Colonoscopy every 3 years | ||
| No adenoma after first low-risk adenoma | Colonoscopy every 10 years | ||
| No adenoma after first high-risk adenoma | Colonoscopy every 5 years | ||
| Second adenomatous polyps | Second low-risk adenoma | Colonoscopy after 5 years | |
| High-risk adenoma following low-risk adenoma | Colonoscopy after 3 years | ||
| Low-risk adenoma following high-risk adenoma | Colonoscopy after 5 years | ||
| Second high-risk adenoma | Colonoscopy after 3 years | ||
| Serrated polyps | Sessile serrated polyp(s) <10 mm with no dysplasia | Colonoscopy every 5 years | |
| Sessile serrated polyp(s) ≥10 mm | Colonoscopy every 3 years | ||
| Sessile serrated polyp with dysplasia | Colonoscopy every 3 years | ||
| Traditional serrated adenoma | Colonoscopy every 3 years | ||
| Serrated polyposis syndrome | Colonoscopy every year | ||
References
- ↑ Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR (2012). "Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer". Gastroenterology. 143 (3): 844–857. doi:10.1053/j.gastro.2012.06.001. PMID 22763141.
- ↑ National Guideline Clearinghouse (NGC). Guideline summary: Follow-up of colorectal polyps or cancer. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 Jan 16. [cited 2017 Dec 28]. Available: https://www.guideline.gov
- ↑ Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ (2017). "Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer". Am. J. Gastroenterol. 112 (7): 1016–1030. doi:10.1038/ajg.2017.174. PMID 28555630.